NCT02507102View on ClinicalTrials.gov

A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

March 26, 2018

Conditions
Glioblastoma Multiforme
Interventions
DEVICE

Voyager

Non-invasive RFE therapy

Trial Locations (1)

3065

St. Vincent's Hospital Melbourne, Melbourne

Sponsors

Lead Sponsor

Nativis, Inc.
All Listed Sponsors
lead

Nativis, Inc.

INDUSTRY